This inventor holds 1 USPTO granted patent. Top assignee: Osi Pharmaceuticals, Inc.. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: The Innovations of Peter Ten Dijke
Introduction
Peter Ten Dijke is a notable inventor based in Port Washington, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of tumor growth inhibitors. His work has implications for cancer treatment and research.
Latest Patents
Peter Ten Dijke holds a patent for "Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof." This invention provides a recombinant nucleic acid vector that encodes a polypeptide of 112 amino acids. The amino acid sequence begins with alanine at position 1 and ends with serine at position 112. This sequence represents a member of the TGF-β family of tumor growth factors. The invention also outlines a method for producing a protein by culturing a host cell under suitable conditions to express the protein and recovering the produced protein.
Career Highlights
Peter Ten Dijke is associated with Osi Pharmaceuticals, Inc., where he has contributed to various research initiatives. His work focuses on innovative solutions in the biotechnology sector, particularly in cancer research.
Collaborations
Some of his notable coworkers include Kenneth K Iwata and John R Stephenson. Their collaborative efforts have further advanced the research and development of tumor growth inhibitors.
Conclusion
Peter Ten Dijke's contributions to biotechnology, particularly in tumor growth inhibitors, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence cancer research and treatment methodologies.